Related Experiment Videos
Commentary on "The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis"
Philip McGuire1,2, Amir Englund1,2, Sagnik Bhattacharyya1,2
1Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Schizophrenia Bulletin
|January 19, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression.
Neuroscience and biobehavioral reviews·2026
Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark.
Psychological medicine·2026
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
From Protective Factors to Mechanisms: Charting the Neurobiology of Schizophrenia Resilience.
Schizophrenia bulletin·2026
Resilience Pathways in Psychosis.
Schizophrenia bulletin·2026
Understanding Resilience in Psychosis: An Emerging Field.
Schizophrenia bulletin·2026
Improving access to dermatologic care: insights from a student-run free clinic.
Proceedings (Baylor University. Medical Center)·2026
Psychoeducation for posttraumatic stress disorder in adults: a systematic review of formats and delivery approaches.
European journal of psychotraumatology·2026
Single-arm feasibility trial of manualized outpatient morita therapy for panic disorder with agoraphobia.
PCN reports : psychiatry and clinical neurosciences·2026